Skip to main content

Table 3 Adverse events spontaneously reported by the volunteers and reported in response to the query of the study investigator

From: Facial nerve stimulation in normal pigs and healthy human volunteers: transitional development of a medical device for the emergency treatment of ischemic stroke

N = 35 Maximum stimulation power achieved, Tesla (number of volunteers)
< 1.0 T (2) 1.0 T (1) 1.2 T (4) 1.4 T (8) 1.6 T (17) 1.8 T (3)
Expected adverse events during stimulation
 Metallic taste sensation 0 0 1 1 1 0
 Vertigo/sensation of movement 0 0 0 1 2 1
 Tinnitus/Ringing ears 0 0 0 0 0 0
Adverse events during stimulation
 Visual flashes 0 0 1 2 3 1
 Nausea 0 0 0 0 2 1
 Sweating 0 0 2 0 7 2
 Jaw pain or soreness 0 0 2 5 11 2
 Neck pain or soreness 0 0 3 0 1 0
Adverse events after stimulation
 Any 0 0 0 0 0 0
  1. Tolerability is shown by the number of volunteers achieving each level of stimulation power